Phytotherapy in endometriosis: an up-to-date review.
Luigi Della CorteMarco NoventaMichal CiebieraMaria MagliarditiZaki SleimanErbil KaramanUrsula CatenaCalogero SalvaggioGiovanni FalzoneSimone GarzonPublished in: Journal of complementary & integrative medicine (2020)
Endometriosis is a benign gynecological disease which symptoms can provide a severe impact on patient's quality of life with subsequent impact on psychological well-being. Different therapeutic strategies are available to treat this disease, such as surgery, hormonal therapies, and nonsteroidal anti-inflammatory drugs. Nevertheless, the efficacy of conventional medical treatments is limited or intermittent in most of the patients due to the associated side effects. Therefore, a woman with endometriosis often search for additional and alternative options, and phytotherapy might be a promising alternative and complementary strategy. Different medicinal plants, multicomponent herbal preparations, and phytochemicals were investigated for pharmacological proprieties in endometriosis therapy. In most of the cases, the effect on endometriosis was related to phenolic compounds, such as flavonoids and phenolic acids reporting anti-inflammatory, proapoptotic, antioxidant, and immunomodulatory functions. Moreover, some phytochemicals have been related to a strong phytoestrogenic effect modulating the estrogen activity. Although promising, available evidence is based on in vitro and animal models of endometriosis with a limited number of well-performed clinical studies. There are almost none randomized control trials in this area. Therefore, properly constructed clinical trials are mandatory to achieve more conclusive results about the promising role of phytotherapy in the management of endometriosis.
Keyphrases
- anti inflammatory
- clinical trial
- end stage renal disease
- healthcare
- chronic kidney disease
- case report
- open label
- newly diagnosed
- signaling pathway
- oxidative stress
- emergency department
- randomized controlled trial
- type diabetes
- metabolic syndrome
- early onset
- high intensity
- phase ii
- adipose tissue
- acute coronary syndrome
- physical activity
- coronary artery disease
- anti inflammatory drugs
- depressive symptoms
- adverse drug